Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1961 Mar;20(1):18–35. doi: 10.1136/ard.20.1.18

Chloroquine Diphosphate in Rheumatoid Arthritis *

A Controlled Trial

A J Popert 1,2, K A E Meijers 1,2,†, J Sharp 1,2, F Bier 1,2
PMCID: PMC1007179  PMID: 13737086

Full text

PDF
22

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAGNALL A. W. The value of chloroquine in rheumatoid disease: a four-year study of continuous therapy. Can Med Assoc J. 1957 Aug 1;77(3):182–194. [PMC free article] [PubMed] [Google Scholar]
  2. BALL J. Serum factor in rheumatoid arthritis agglutinating sensitized sheep red cells. Lancet. 1950 Nov 11;2(6637):520–524. doi: 10.1016/s0140-6736(50)91500-5. [DOI] [PubMed] [Google Scholar]
  3. BLEIL D. C. Unusual toxic manifestations to amodiaquin (camoquin). AMA Arch Derm. 1958 Jan;77(1):106–107. doi: 10.1001/archderm.1958.01560010108016. [DOI] [PubMed] [Google Scholar]
  4. COHEN A. S., CALKINS E. A controlled study of chloroquine as an antirheumatic agent. Arthritis Rheum. 1958 Aug;1(4):297–312. doi: 10.1002/art.1780010403. [DOI] [PubMed] [Google Scholar]
  5. DE FOREST G. K., MUCCI M. B., BOISVERT P. L. Two-year comparative study of serial hemagglutination tests done on groups of rheumatoid arthritis patients. Arthritis Rheum. 1958 Oct;1(5):387–391. doi: 10.1002/art.1780010502. [DOI] [PubMed] [Google Scholar]
  6. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association. Ann Rheum Dis. 1959 Mar;18(1):49–53. [PMC free article] [PubMed] [Google Scholar]
  7. DUTHIE J. J., THOMPSON M., WEIR M. M., FLETCHER W. B. Medical and social aspects of the treatment of rheumatoid arthritis; with special reference to factors affecting prognosis. Ann Rheum Dis. 1955 Jun;14(2):133–149. doi: 10.1136/ard.14.2.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. FREEDMAN A. Chloroquine and rheumatoid arthritis; a short-term controlled trial. Ann Rheum Dis. 1956 Sep;15(3):251–257. doi: 10.1136/ard.15.3.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HOBBS H. E., CALNAN C. D. The ocular complications of chloroquine therapy. Lancet. 1958 Jun 7;1(7032):1207–1209. doi: 10.1016/s0140-6736(58)91911-1. [DOI] [PubMed] [Google Scholar]
  10. HOBBS H. E., SORSBY A., FREEDMAN A. Retinopathy following chloroquine therapy. Lancet. 1959 Oct 3;2(7101):478–480. doi: 10.1016/s0140-6736(59)90604-x. [DOI] [PubMed] [Google Scholar]
  11. KELLGREN J. H., BALL J. Clinical significance of the rheumatoid serum factor. Br Med J. 1959 Feb 28;1(5121):523–531. doi: 10.1136/bmj.1.5121.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. KERSLEY G. D., PALIN A. G. Amodiaquine and hydroxychloroquine in rheumatoid arthritis. Lancet. 1959 Nov 21;2(7108):886–888. doi: 10.1016/s0140-6736(59)90808-6. [DOI] [PubMed] [Google Scholar]
  13. Mann I. "BLUE HALOES" IN ATEBRIN WORKERS. Br J Ophthalmol. 1947 Jan;31(1):40–46. doi: 10.1136/bjo.31.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. PAGE F. Treatment of lupus erythematosus with mepacrine. Lancet. 1951 Oct 27;2(6687):755–758. doi: 10.1016/s0140-6736(51)91643-1. [DOI] [PubMed] [Google Scholar]
  16. SCHERBEL A. L., HARRISON J. W., ATDJIAN M. Further observations on the use of 4-aminoquinoline compounds in patients with rheumatoid arthritis or related diseases. Cleve Clin Q. 1958 Apr;25(2):95–111. doi: 10.3949/ccjm.25.2.95. [DOI] [PubMed] [Google Scholar]
  17. STUART D., AUKLAND K. Chloroquinbehandling av polyarthritis chronica. Nord Med. 1958 Dec 4;60(49):1759–1761. [PubMed] [Google Scholar]
  18. ZELLER R. W., DEERING D. Corneal complication of chloroquine (aralen) phosphate therapy. J Am Med Assoc. 1958 Dec 27;168(17):2263–2264. doi: 10.1001/jama.1958.63000170007012b. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES